IMMUNOSEQ CASE STUDIES
See how researchers around the world are using the immunoSEQ Assay to drive discoveries
Our assays provide accurate, quantitative, high-throughput sequencing of the CDR3 variable chain of immune cell receptors.
The CDR3 sequence acts as a unique tag for a clonal lineage, enabling the tracking of T- and B- cells over time, characterizing the diversity of the immune repertoire, and measuring the dynamics of disease and treatment.
- Evaluating interaction of tumor, peripheral and clinical factors in urothelial carcinoma patients’ responses to treatment, Snyder, et al. (2017)
- Efficacy of therapies in dual tumor mouse model, Dovedi, et al. (2017)
- Tracking Glioma infiltrating T Cells, Prins, et al. (2016)
- Evaluating a dendritic cell vaccine, Carreno, et al. (2015)
- PD-1 and adaptive immune resistance, Tumeh, et al. (2014)
- Identifying cytomegalovirus exposure history and HLA-mediated effects, Emerson, et al. (2017)
- Characterizing dynamics of antigen specific cTfh cell response to vaccination, Herati, et al. (2017)
- Evaluating drivers for increased CD8+ T cells cycling in untreated HIV-1 infected patients, Younes, et al. (2016)
- Immunocompetence in Dual Transplant, Leventhal, et al. (2015)
- Impact of CMV Reactivation, Suessmuth, et al. (2015)
Researching Immune Tolerance in Transplantation